Joining the Winthrop P. Rockefeller Cancer Institute’s growing team of clinicians is Shi-Ming Tu, M.D., who specializes in the treatment of genitourinary cancers.
A fellowship-trained medical oncologist from MD Anderson Cancer Center with 30 years of clinical experience, Tu treats cancers of the urinary system of men and women and the reproductive organs in men. Prostate cancer is the most common genitourinary malignancy and the third highest cancer diagnosis in Arkansas with an estimated 2,680 cases per year
“Dr. Tu will bolster a growing team of physicians and scientists in the battle against genitourinary malignancies,” said Michael Birrer, M.D., Ph.D., Cancer Institute director and UAMS vice chancellor. “He joins a multidisciplinary team of clinicians committed to holistic and patient-centered cancer care, including uro-oncologic surgeons, radiation oncologists specializing in modern treatments of GU tumors and other clinical specialists.”
Before joining UAMS, Tu served for 28 years on the medical oncology faculty at the University of Texas MD Anderson Cancer Center in Houston. There, he conducted clinical and translational research relating to genitourinary cancers, authored or co-authored more than 100 peer-reviewed research articles, presented at national and international conferences and developed a highly regarded clinical practice. In addition to clinical work on the main campus, he also conducted specialty clinics at one of MD Anderson’s satellite network sites in the greater Houston area.
After earning his medical degree from Washington University in St. Louis and completing residency at the University of Illinois Hospitals, Tu completed a clinical fellowship in genitourinary medical oncology at MD Anderson Cancer Center. He holds a bachelor’s degree from Johns Hopkins University.